CALLOS ANDREW (Chief Commercial Officer) sold 3.6% of their position (1.71K shares) of CYTOKINETICS INC on the open market
Open‑market sale worth $104.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/16/2026ACC: 0001061983-26-000019
Officer· Chief Commercial Officer
Since Mar 2021
-1.71K
Net shares
Net seller
$104.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.71K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.71K
Price / share
$61.03
Trade value
$104.30K
% of position
3.6%
3/16/2026
47.86K→46.15K
Total
Net shares
−1.71K
Net value
-$104.30K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/16/2026 | S · Sale | −1.71K | $61.03 | $104.30K | 3.6% | 47.86K | 46.15K |
| Total | −1.71K | -$104.30K | ||||||
Derivative Transactions0
No derivative transactions reported